» Articles » PMID: 9326638

Generation of CD8+ T Cells Specific for Transporter Associated with Antigen Processing Deficient Cells

Overview
Specialty Science
Date 1997 Oct 23
PMID 9326638
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cells with impaired transporter associated with antigen processing (TAP) function express low levels of cell surface major histocompatibility complex (MHC) class I molecules, and are generally resistant to lysis by MHC class I restricted cytotoxic T lymphocytes (CTLs). Here we report the generation of MHC class I restricted CD8(+) CTLs that surprisingly require target cell TAP deficiency for efficient recognition. C57BL/6 (B6) mice immunized with syngenic B7-1 (CD80) expressing TAP-deficient cells generated a potent CTL response against both TAP-deficient RMA-S tumor cells and TAP-deficient Con A blasts, whereas the corresponding TAP-expressing target cells were considerably less susceptible or resistant to lysis. The CTL epitopes recognized were expressed also by the human TAP-deficient cell line T2, transfected with appropriate MHC class I molecules. B6 mice immunized with B7-1-transfected TAP-deficient RMA-S cells were protected from outgrowth of a subsequent RMA-S tumor challenge. These findings are discussed in relation to the biochemical nature of MHC class I dependent CTL epitopes associated with impaired TAP function, as well as implications for immunotherapy and autoimmunity.

Citing Articles

Occlusion of TCR binding to HLA-A*11:01 by a non-pathogenic human alloantibody.

Hamidinia M, Gu Y, Ser Z, Brzostek J, Tay N, Yap J Cell Mol Life Sci. 2025; 82(1):94.

PMID: 40009199 PMC: 11865395. DOI: 10.1007/s00018-025-05614-y.


Allosteric inhibition of the T cell receptor by a designed membrane ligand.

Ye Y, Morita S, Chang J, Buckley P, Wilhelm K, DiMaio D Elife. 2023; 12.

PMID: 37796108 PMC: 10554751. DOI: 10.7554/eLife.82861.


Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition.

Sandalova T, Sala B, Achour A Front Chem. 2022; 10:861609.

PMID: 36017166 PMC: 9395651. DOI: 10.3389/fchem.2022.861609.


Spotlight on TAP and its vital role in antigen presentation and cross-presentation.

Mantel I, Sadiq B, Blander J Mol Immunol. 2022; 142:105-119.

PMID: 34973498 PMC: 9241385. DOI: 10.1016/j.molimm.2021.12.013.


MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.

Shklovskaya E, Rizos H Int J Mol Sci. 2021; 22(13).

PMID: 34201655 PMC: 8268865. DOI: 10.3390/ijms22136741.


References
1.
Ljunggren H, Van Kaer L, Sabatine M, Auchincloss Jr H, Tonegawa S, Ploegh H . MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice. Int Immunol. 1995; 7(6):975-84. DOI: 10.1093/intimm/7.6.975. View

2.
Franksson L, Petersson M, Kiessling R, Karre K . Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells. Eur J Immunol. 1993; 23(10):2606-13. DOI: 10.1002/eji.1830231034. View

3.
Nair S, Snyder D, Gilboa E . Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo. J Immunol. 1996; 156(5):1772-80. View

4.
Huang A, Bruce A, Pardoll D, Levitsky H . Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?. J Exp Med. 1996; 183(3):769-76. PMC: 2192347. DOI: 10.1084/jem.183.3.769. View

5.
Johnston J, Malacko A, Mizuno M, McGowan P, Hellstrom I, Hellstrom K . B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes. J Exp Med. 1996; 183(3):791-800. PMC: 2192349. DOI: 10.1084/jem.183.3.791. View